Study of Neoadjuvant Chemotherapy With Nanoparticle Albumin Bound Paclitaxel, Doxorubicin and Cyclophosphamide (NAC) in Patients With Stages II-III Breast Cancer
This study is currently recruiting participants.
Verified April 2013 by University of Utah
Study NCT01090128
Information provided by University of Utah
First Received on March 17, 2010.
Last Updated on April 10, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
